HER2 Support Group Forums - View Single Post - Trastuzumab should remain as standard of care for HER2-positive breast cancer

News · 10-02-2014, 02:12 AM

Analysis of more than 8,000 women who participated in the world's largest study of two treatments for HER2-positive breast cancer reinforces other findings from the clinical trial showing that...

More...

10-02-2014, 02:12 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,103	Trastuzumab should remain as standard of care for HER2-positive breast cancer Analysis of more than 8,000 women who participated in the world's largest study of two treatments for HER2-positive breast cancer reinforces other findings from the clinical trial showing that... More...